BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11932138)

  • 21. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA; Isenberg HD; France KA; Jenkins SG
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1973-6. PubMed ID: 8878565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.
    Butler DL; Gagnon RC; Miller LA; Poupard JA; Felmingham D; Grüneberg RN
    J Antimicrob Chemother; 1999 Jun; 43(6):777-82. PubMed ID: 10404316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative susceptibility of Yersinia enterocolitica, Eikenella corrodens, and penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to beta-lactam and alternative antimicrobial agents.
    Goldstein EJ; Cherubin CE; Corrado ML; Sierra MF
    Rev Infect Dis; 1982; 4 Suppl():S406-10. PubMed ID: 6294791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.
    Moellering RC; Wennersten C; Weinstein AJ
    Antimicrob Agents Chemother; 1973 Apr; 3(4):526-9. PubMed ID: 4208292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.
    Doit CP; Bonacorsi SP; Fremaux AJ; Sissia G; Cohen R; Geslin PL; Bingen EH
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2655-9. PubMed ID: 7872763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative bactericidal activity of penicillin-netilmicin and penicillin-gentamicin against enterococci.
    Rahal JJ; Simberkoff MS
    J Antimicrob Chemother; 1986 May; 17(5):585-91. PubMed ID: 3636323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
    Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
    J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae.
    Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA
    Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of beta-lactam antibiotics combined with gentamicin against penicillin-resistant pneumococcal pneumonia in CBA/J mice.
    Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1999 Mar; 43(3):367-71. PubMed ID: 10223592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
    Martin SJ; Garvin CG; McBurney CR; Sahloff EG
    J Antimicrob Chemother; 2001 May; 47(5):581-7. PubMed ID: 11328768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of penicillin minimum inhibitory concentration in the synergy between penicillin and gentamicin in viridans-group streptococci].
    Vigliarolo L; Ramírez MS; Centrón D; Lopardo H
    Rev Argent Microbiol; 2007; 39(2):107-12. PubMed ID: 17702259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
    Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of penicillin susceptibility in clinical isolates of Streptococcus pneumoniae oxacillin resistant.
    Mosca A; Del Prete R; D'Alagni M; Bilancia R; Miragliotta G
    Eur J Epidemiol; 1996 Dec; 12(6):643-5. PubMed ID: 8982626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 39. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy.
    Pantosti A; D'Ambrosio F; Bordi E; Scotto D'Abusco A; Del Grosso M
    Clin Microbiol Infect; 2001 Sep; 7(9):503-6. PubMed ID: 11678935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci.
    Barakett V; Lesage D; Delisle F; Burghoffer B; Richard G; Vergez P; Petit JC
    J Antimicrob Chemother; 1993 Jan; 31(1):105-9. PubMed ID: 8444654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.